Immunization, HepB3 in United States of America
United States of America: Immunization, HepB3 was 93.0% in 2024. ▲ Rising
Immunization, HepB3 in United States of America, 1993–2024
Source: World Health Organization (WHO). Measured in % of one-year-old children.
Analysis
In 2024, immunization, hepb3 in United States of America stood at 93.0%.
That represents a change of up 1.1% over ten years.
Over the whole period, immunization, hepb3 in United States of America peaked at 94.0% in 2008 and was at its lowest, 16.0%, in 1993.
That places United States of America 72nd out of 188 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 32 years of available data.
Immunization, HepB3 in United States of America, year by year
| Year | % of one-year-old children | Change |
|---|---|---|
| 1993 | 16.0% | — |
| 1994 | 42.0% | +162.5% |
| 1995 | 68.0% | +61.9% |
| 1996 | 82.0% | +20.6% |
| 1997 | 84.0% | +2.4% |
| 1998 | 87.0% | +3.6% |
| 1999 | 88.0% | +1.1% |
| 2000 | 90.0% | +2.3% |
| 2001 | 89.0% | -1.1% |
| 2002 | 88.0% | -1.1% |
| 2003 | 92.0% | +4.5% |
| 2004 | 92.0% | +0.0% |
| 2005 | 93.0% | +1.1% |
| 2006 | 93.0% | +0.0% |
| 2007 | 93.0% | +0.0% |
| 2008 | 94.0% | +1.1% |
| 2009 | 92.0% | -2.1% |
| 2010 | 92.0% | +0.0% |
| 2011 | 91.0% | -1.1% |
| 2012 | 90.0% | -1.1% |
| 2013 | 91.0% | +1.1% |
| 2014 | 92.0% | +1.1% |
| 2015 | 92.0% | +0.0% |
| 2016 | 93.0% | +1.1% |
| 2017 | 91.0% | -2.2% |
| 2018 | 91.0% | +0.0% |
| 2019 | 91.0% | +0.0% |
| 2020 | 91.0% | +0.0% |
| 2021 | 92.0% | +1.1% |
| 2022 | 93.0% | +1.1% |
| 2023 | 93.0% | +0.0% |
| 2024 | 93.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 66.7% | 16.0% | 88.0% | 7 |
| 2000s | 91.6% | 88.0% | 94.0% | 10 |
| 2010s | 91.4% | 90.0% | 93.0% | 10 |
| 2020s | 92.4% | 91.0% | 93.0% | 5 |
Countries ranked near United States of America
More health data for United States of America
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.1867 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,069 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4,015 deaths (2100)
- Population ages 05-09, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, female, per capita 0.0277 units per person (2025)
- Population ages 05-09, male, annual growth rate -1.74 % change on previous year (2025)
- Population ages 05-09, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, male, per capita 0.0291 units per person (2025)
- Population ages 10-14, female, annual growth rate -0.6756 % change on previous year (2025)
Frequently asked questions
- What is immunization, hepb3 in United States of America?
- Immunization, hepb3 in United States of America was 93.0% in 2024, according to World Health Organization (WHO).
- What is the highest immunization, hepb3 recorded in United States of America?
- The highest recorded value was 94.0% in 2008.
- What is the lowest immunization, hepb3 recorded in United States of America?
- The lowest recorded value was 16.0% in 1993.
- How does United States of America rank for immunization, hepb3?
- United States of America ranks 72nd out of 188 countries with data for 2024.
- Is immunization, hepb3 rising or falling in United States of America?
- Over the last ten years it is up 1.1%. The long-run trend across the full record is rising.
- Where does this United States of America data come from?
- The figures come from World Health Organization (WHO), published as part of Immunization, HepB3 (% of one-year-old children). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 32 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.